Search
Consider risks and alternatives before deciding on LASIK surgery: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/january-lasik-surgery.html
Patients considering LASIK vision correction surgery should consider the risks as well as benefits and see a doctor who can assess whether they are a good candidate for the procedure, according to an ophthalmologist at UT Southwestern Medical Center.
How parents can help their kids with asthma avoid serious attacks: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/october-kids-with-asthma.html
Changes in weather that accompany the return to school each fall can create a challenging environment for children who suffer from asthma, the most common pediatric chronic illness.
COVID-19 vaccine’s effectiveness diminishes with age, UTSW research shows: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/november-covid-19-vaccines-effectiveness.html
The Pfizer-BioNTech COVID-19 vaccine limits transmission, hospitalization, and death from COVID-19 even among patients infected by variants of the virus, but the effectiveness of antibodies it generates diminishes as patients get older, according to a study by UT Southwestern researchers.
Study sheds new light on urinary tract infections in postmenopausal women: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2019/postmenopausal-uti.html
A UT Southwestern study suggests why urinary tract infections have such a high recurrence rate in postmenopausal women.
Cell competition may explain cancer relapses, research suggests: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/november-cell-competition.html
A normal process called cell competition, in which healthy tissues eliminate unhealthy cells, could be responsible for cancer relapses in patients months or years after they were declared cancer-free, a new study by UT Southwestern researchers suggests.
Researchers discover new molecular driver of retinoblastoma: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/september-retinoblastoma.html
Researchers have discovered that a molecule – estrogen-related receptor gamma, or ESRRG – becomes hyperactive and promotes tumor cell survival in retinoblastoma.
UTSW researchers discover molecular switch for heart regeneration: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/october-heart-regeneration.html
Scientists at UT Southwestern have discovered a molecular switch to restore the regenerative ability of adult heart cells.
UTSW infectious diseases experts offer advice on second COVID-19 booster : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/second-booster.html
Individuals should weigh their own personal health and risk levels in deciding when to receive a second booster of the COVID-19 vaccine, UT Southwestern infectious diseases experts advise.
UTSW study: RNA exosome key for B cell development: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/rna-exosome-key.html
New research from UT Southwestern suggests that RNA exosomes– the cellular machines that degrade old molecules of RNA – play a key role in the development of B cells, which are critical to the immune system’s ability to protect against infection.
UTSW researchers part of winning global team in Cancer Grand Challenges : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/cancer-grand-challenges.html
UT Southwestern researchers Zhijian “James” Chen, Ph.D., and Sihan Wu, Ph.D., are part of a team that has been awarded a Cancer Grand Challenges grant, a unique award that aims to solve some of cancer’s toughest problems by bringing together global teams with diverse areas of expertise.